In March 212, Wang Laoji's trademark arbitration result was postponed, but the contest between GPHL and Jiaduobao, a subsidiary of Hong Kong Hongdao Group, gradually warmed up. On March 21st, 212, in order to strengthen the market appeal of Wang Laoji in red cans, Wang Laoji in Jiaduobao PEP bottles had entered all major urban terminal markets in early 212. In addition, the new products Wang Laoji Guiling Ointment and Golden Pot Gynostemma pentaphyllum authorized by Guangzhou Pharmaceutical Group's Big Health Industry also began to be listed for distribution.
In April p>212, the highly anticipated Wang Laoji incident made new progress. Recently, Jiaduobao, Hongdao Group, officially issued a statement saying that the red pot of Wang Laoji herbal tea produced by Jiaduobao has been fully packaged, "the purpose is to enable consumers to correctly identify the authentic herbal tea produced by Jiaduobao, protect the singleness and purity of authentic herbal tea, and thus protect and promote the healthy development of herbal tea culture." Vice President Jia Duobao said, "The launch of the new packaging is an attempt to be based on' authenticity' and unswervingly inherit and carry forward the herbal tea culture."
Guangzhou Pharmaceutical Co., Ltd. and Baiyunshan A, a subsidiary of GPHL, were exceptionally strong in May 212. On May 11, 212, both stocks had daily limit. Since the first six trading days of May 11, Guangzhou Pharmaceutical Co., Ltd. has increased by 29%. The information disclosed by Guangzhou Pharmaceutical last night showed that Hongdao (Group) would stop using the "Wang Lao Ji" trademark, which means that GPHL finally took the "Wang Lao Ji" trademark into its pocket.
In June p>212, the application of Jiaduobao's parent company Hongdao (Group) Co., Ltd. to cancel the arbitration result was filed by Beijing No.1 Intermediate People's Court on May 17th. According to the normal procedure, the court will make a decision within two months after filing the case, that is to say, the Beijing Intermediate People's Court will make a final ruling on whether to cancel the arbitration at the latest on July 17. Guangzhou SASAC is full of confidence in Guangzhou Pharmaceutical Group's operation of the red pot Wang Laoji!
On July 1th, 212, GPHL held a media communication meeting, and announced that it would sue Hongdao Group and Jiaduobao Company, and take legal action against them for infringing Wang Laoji's well-known commodity decoration right, and said that it would be filed. Since then, the focus of Wang Laoji brand competition has shifted from trademark to product decoration. And where will Wang Laoji's red can decoration belong? The decoration right of "Wang Lao Ji" red cans has become the focus of this competition.
In August, 212, the protracted battle for the trademark of "Wang Lao Ji" broke out again. Guangzhou Pharmaceutical Co., Ltd. announced that its controlling shareholder, GPHL, had received an arbitration notice from China International Economic and Trade Arbitration Commission dated July 31, 212, and Jiaduobao's parent company Hongdao Group had filed an arbitration application for the dispute arising from the Trademark Authorization Agreement signed with GPHL in 23. According to reports, the dispute surrounding this arbitration is the Trademark License Agreement signed by Jiaduobao's parent company Hongdao Group and GPHL on May 2, 23, which stipulated that Hongdao Group was granted an exclusive license to use the "Wang Lao Ji" trademark, valid until January 19, 213.
during this period of time in August 212, jiaduobao was still engaged in a fierce struggle against Guangzhou Pharmaceutical's "red can" packaging infringement case. On August 7, 212, Guangzhou Pharmaceutical Group received a new arbitration notice. According to lawyers' analysis, the new arbitration result may be delayed until April 213. In April 211, GPHL filed an arbitration application with the Arbitration Commission, and in May, the trademark case of Wang Laoji was filed.
On May 11, 212, GPHL announced that it had received the arbitration award from China International Economic and Trade Arbitration Commission on May 11, and the Supplementary Agreement on Trademark License of Wang Lao Ji and Supplementary Agreement on Trademark License Contract of Wang Lao Ji were ruled invalid, thus ruling that Jiaduobao Group stopped using the trademark of Wang Lao Ji.
On May 16th, 212, Jiaduobao held a media briefing to respond to the trademark case for the first time.
On May 21st, 212, GPHL held a media briefing, and announced that it would launch the red jar Wang Laoji to the market in early June.
On May 25th, 212, GPHL issued a "solemn statement", claiming that Jiaduobao was still selling "Red Canned Wang Laoji" in the market, which constituted infringement.
on may 27, 212, jiaduobao issued a statement saying that Hongdao group was not satisfied with the ruling made by China international economic and trade arbitration commission on "Wang Lao Ji's trademark right", and on may 17, 212, it filed an application with Beijing No.1 intermediate court to cancel the ruling.
On July 4th, 212, two law firms represented by GPHL officially announced at the media communication meeting that GPHL had launched legal proceedings to protect the rights of a large number of herbal teas with the word "Wang Lao Ji" on the market. During this period, Jiaduobao and the sellers of Wang Lao Ji herbal teas who infringed on them have been brought to court by GPHL and accepted. Guangzhou pharmaceutical co., ltd. won the trademark of Wang laoji
after taking back the right to use the trademark of Wang laoji, Guangzhou pharmaceutical co., ltd. held a high-profile press conference yesterday, pointing out that the "mysterious contract" previously announced by Jiaduobao was suspected of forgery. GPHL said that the "mysterious contract" presented by Jiaduobao has many alterations and contradictions, and they have reported this situation to the public relations organ.
On July 13th, 212, Beijing No.1 Intermediate People's Court made a final judgment, and GPHL won the trademark lawsuit of Wang Laoji.
Guangzhou Pharmaceutical Group and Taizhou Municipal People's Government signed a strategic cooperation agreement on August 1, 212. Guangzhou Pharmaceutical Wang Laoji Health Company will build its own Wang Laoji canned and bottled herbal tea production base in Taizhou Pharmaceutical High-tech Industrial Development Zone, with a planned production capacity of 36 million cans and an annual output value of 1 billion yuan. It is expected to be completed and put into production within 1 months.
In late June, Wang Laoji, a red jar of Guangzhou Pharmaceutical Co., Ltd., signed an OEM agreement with more than 3 food production enterprises, raw material and packaging suppliers, such as Uni-President, Yinlu and Wellcome, which means that Guangzhou Pharmaceutical Co., Ltd. is speeding up the production capacity construction after recovering Wang Laoji's trademark, and gradually shifting from entrusted processing to the combination of processing and self-production.
Li Chuyuan, general manager of GPHL, said that in addition to East China, GPHL will establish production bases in North China, Northwest China, Central South China and Southwest China. In December 214, the court ruled that Guangdong Jiaduobao compensated the plaintiff GPHL for economic losses of 15 million yuan and reasonable rights protection expenses of 265,21 yuan within seven days from the effective date of the judgment.